Trial shows using two drugs not better than one when treating MRSA blood infections

(University of Melbourne) Researchers attempting to improve the treatment for methicillin-resistant Staphylococcus aureus (MRSA) blood infections have discovered the combination of two antibiotics was no better than one, and led to more adverse effects. In what is the biggest trial of MRSA bloodstream infections to date, (352 participants from Australia, Singapore, New Zealand and Israel), the CAMERA2 clinical trial, researchers were surprised to see the drug combination wasn't as effective as anticipated.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news